Status:
COMPLETED
Patient Reported Outcomes in Stroke Care
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Stroke
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The presented study is an explorative prospective study. First, it focusses on the longitudinal analysis of outcome quality in stroke treatment (12 months). Particularly, it addresses patient reported...
Detailed Description
With a shift in focus to patient-centered health care and a constant effort to improve the quality of treatment, the role of the patient's perception of his/her medical care becomes essential. Patient...
Eligibility Criteria
Inclusion
- Patients in inpatient care in the stroke unit of the UKE with the following diagnoses (ICD-10):
- Ischemic attack (I63),
- Transient ischemic attack (G45)
- Intracerebral hemorrhage (I64)
- Written informed consent
Exclusion
- Substantially impaired communication capacity due to aphasia or dementia
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
975 Patients enrolled
Trial Details
Trial ID
NCT03795948
Start Date
July 1 2017
End Date
December 31 2019
Last Update
April 10 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Neurology, University Medical Center Hamburg-Eppendorf (UKE)
Hamburg, Germany, 20246